• 2024
  Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N, A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
• 2022
  Launay O, Artaud C, Lachâtre M, Ait-Ahmed M, Klein J, Luong Nguyen LB, Durier C, Jansen B, Tomberger Y, Jolly N, Grossmann A, Tabbal H, Brunet J, Gransagne M, Choucha Z, Batalie D, Delgado A, Müllner M, Tschismarov R, Berghmans PJ, Martin A, Ramsauer K, Escriou N, Gerke C, , Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study., EBioMedicine 2022 Jan; 75(): 103810.
• 2021
  Sarah Lesage, Maxime Chazal, Guillaume Beauclair, Damien Batalie, Silvia Cerboni, Elodie Couderc, Aurianne Lescure, Elaine del Nery, Frédéric Tangy, Annette Martin, Nicolas Manel, Nolwenn Jouvenet, Discovery of genes that modulate flavivirus replication in an interferon-dependent manner, Journal of Molecular Biology, 2021, pp.167277. ⟨10.1016/j.jmb.2021.167277⟩.
• 2020
  Ku MW, Bourgine M, Authié P, Lopez J, Nemirov K, Moncoq F, Noirat A, Vesin B, Nevo F, Blanc C, Souque P, Tabbal H, Simon E, Hardy D, Le Dudal M, Guinet F, Fiette L, Mouquet H, Anna F, Martin A, Escriou N, Majlessi L, Charneau P, , Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models., Cell Host Microbe 2021 Feb 10;29(2):236-249: .
• 2018
  Aicher S, Kakkanas A, Cohen L, Blumen B, Oprisan G, Njouom R, Meurs EF, Mavromara P, Martin A, Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes, Sci Rep 2018 Jul;8(1):11185.
• 2018
  Sinigaglia L, Gracias S, Décembre E, Fritz M, Bruni D, Smith N, Herbeuval JP, Martin A, Dreux M, Tangy F, Jouvenet N, , Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons., Sci Rep 2018 Jul; 8(1): 10889.
• 2018
  Boukadida C, Fritz M, Blumen B, Fogeron ML, Penin F, Martin A, NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities, PLoS Pathog. 2018 02;14(2):e1006863.
• 2015
  Marnata C, Saulnier A, Mompelat D, Krey T, Cohen L, Boukadida C, Warter L, Fresquet J, Vasiliauskaite I, Escriou N, Cosset FL, Rey FA, Lanford RE, Karayiannis P, Rose NJ, Lavillette D, Martin A, Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction, J. Virol. 2015 Dec;89(23):12131-44.
• 2015
  Fogeron ML, Paul D, Jirasko V, Montserret R, Lacabanne D, Molle J, Badillo A, Boukadida C, Georgeault S, Roingeard P, Martin A, Bartenschlager R, Penin F, Böckmann A, Functional expression, purification, characterization, and membrane reconstitution of non-structural protein 2 from hepatitis C virus, Protein Expr. Purif. 2015 Dec;116:1-6.
• 2014
  Boukadida C, Marnata C, Montserret R, Cohen L, Blumen B, Gouttenoire J, Moradpour D, Penin F, Martin A, NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies, J. Virol. 2014 Jul;88(13):7426-44.
• 2010
  Benureau Y, Warter L, Malcolm BA, Martin A, A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication, Virology 2010 Oct;406(2):228-40.
• 2010
  Krey T, d'Alayer J, Kikuti CM, Saulnier A, Damier-Piolle L, Petitpas I, Johansson DX, Tawar RG, Baron B, Robert B, England P, Persson MA, Martin A, Rey FA, The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule, PLoS Pathog. 2010 Feb;6(2):e1000762.
• 2009
  Weatherford T, Chavez D, Brasky KM, Lemon SM, Martin A, Lanford RE, Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck, J. Virol. 2009 Aug;83(16):8062-75.
• 2009
  Warter L, Cohen L, Benureau Y, Chavez D, Yang Y, Bodola F, Lemon SM, Traboni C, Lanford RE, Martin A, A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B, PLoS ONE 2009;4(2):e4419.
• 2008
  Mankouri J, Milward A, Pryde KR, Warter L, Martin A, Harris M, A comparative cell biological analysis reveals only limited functional homology between the NS5A proteins of hepatitis C virus and GB virus B, J. Gen. Virol. 2008 Aug;89(Pt 8):1911-20.
• 2007
  Chevalier C, Saulnier A, Benureau Y, Fléchet D, Delgrange D, Colbère-Garapin F, Wychowski C, Martin A, Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs, Mol. Ther. 2007 Aug;15(8):1452-62.
• 2006
  Hourioux C, Ait-Goughoulte M, Patient R, Fouquenet D, Arcanger-Doudet F, Brand D, Martin A, Roingeard P, Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane, Cell. Microbiol. 2007 Apr;9(4):1014-27.
• 2006
  Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford RE, Weinman SA, Lemon SM, Martin A, Li K, GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS, J. Virol. 2007 Jan;81(2):964-76.
• 2006
  Targett-Adams P, Schaller T, Hope G, Lanford RE, Lemon SM, Martin A, McLauchlan J, Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo, J. Biol. Chem. 2006 Sep;281(39):29221-7.
• 2006
  Martin A, Lemon SM, Hepatitis A virus: from discovery to vaccines, Hepatology 2006 Feb;43(2 Suppl 1):S164-72.
• 2005
  Rijnbrand R, Yang Y, Beales L, Bodola F, Goettge K, Cohen L, Lanford RE, Lemon SM, Martin A, A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins, Hepatology 2005 May;41(5):986-94.
• 2004
  Ghibaudo D, Cohen L, Penin F, Martin A, Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein, J. Biol. Chem. 2004 Jun;279(24):24965-75.
• 2003
  Martin A, Bodola F, Sangar DV, Goettge K, Popov V, Rijnbrand R, Lanford RE, Lemon SM, Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA, Proc. Natl. Acad. Sci. U.S.A. 2003 Aug;100(17):9962-7.
• 2002
  Cohen L, Bénichou D, Martin A, Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis, J. Virol. 2002 Aug;76(15):7495-505.
• 2001
  Beard MR, Cohen L, Lemon SM, Martin A, Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction, J. Virol. 2001 Feb;75(3):1414-26.